|
US3155670A
(en)
|
1962-06-22 |
1964-11-03 |
Res Lab Dr C Janssen N V |
1-oxo-2, 4, 8, triaza-spiro (4, 5) decanes
|
|
US3155669A
(en)
|
1962-06-22 |
1964-11-03 |
Res Lab Dr C Janssen N V |
2, 4, 8-triaza-spiro (4, 5) dec-2-enes
|
|
US3471515A
(en)
|
1965-02-01 |
1969-10-07 |
Sandoz Ag |
(2-hydroxy-3-substituted aminopropoxy)indoles
|
|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
GB1308191A
(en)
|
1970-04-06 |
1973-02-21 |
Science Union & Cie |
Thiochroman derivatives and a process for preparing them
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
DE3008993A1
(de)
|
1980-03-08 |
1981-10-01 |
Röhm Pharma GmbH, 6100 Darmstadt |
Pharmazeutische zubereitungen
|
|
IE52768B1
(en)
|
1981-04-06 |
1988-02-17 |
Boots Co Ltd |
1-arylcyclobutylalkylamine compounds useful as therapeutic agents
|
|
ZA821577B
(en)
|
1981-04-06 |
1983-03-30 |
Boots Co Plc |
Therapeutic agents
|
|
JPS5940638A
(ja)
|
1982-08-30 |
1984-03-06 |
Fuji Photo Film Co Ltd |
直接ポジ用ハロゲン化銀写真乳剤
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
GB8531071D0
(en)
|
1985-12-17 |
1986-01-29 |
Boots Co Plc |
Therapeutic compound
|
|
GB8704777D0
(en)
|
1987-02-28 |
1987-04-01 |
Boots Co Plc |
Medical treatment
|
|
JP2675573B2
(ja)
|
1988-03-31 |
1997-11-12 |
科研製薬株式会社 |
脳機能改善剤
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
IE61928B1
(en)
|
1988-11-29 |
1994-11-30 |
Boots Co Plc |
Treatment of obesity
|
|
GB8909209D0
(en)
|
1989-04-22 |
1989-06-07 |
Wyeth John & Brother Ltd |
Piperazine derivatives
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
US5250534A
(en)
|
1990-06-20 |
1993-10-05 |
Pfizer Inc. |
Pyrazolopyrimidinone antianginal agents
|
|
US5104899A
(en)
|
1990-08-13 |
1992-04-14 |
Sepracor, Inc. |
Methods and compositions for treating depression using optically pure fluoxetine
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
EP0554172B1
(en)
|
1992-01-28 |
1998-04-29 |
Fujitsu Limited |
Color surface discharge type plasma display device
|
|
US5780051A
(en)
|
1992-04-02 |
1998-07-14 |
Dynagen, Inc. |
Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
|
|
AU4542893A
(en)
|
1992-06-23 |
1994-01-24 |
Sepracor, Inc. |
Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine
|
|
AU4542993A
(en)
|
1992-06-23 |
1994-01-24 |
Sepracor, Inc. |
Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
GB9311920D0
(en)
|
1993-06-09 |
1993-07-28 |
Pfizer Ltd |
Therapeutic agents
|
|
US5459164A
(en)
|
1994-02-03 |
1995-10-17 |
Boots Pharmaceuticals, Inc. |
Medical treatment
|
|
GB9402641D0
(en)
|
1994-02-11 |
1994-04-06 |
Boots Co Plc |
Therapeutic agents
|
|
CA2134038C
(en)
|
1994-06-16 |
1997-06-03 |
David Taiwai Wong |
Potentiation of drug response
|
|
AU3354895A
(en)
|
1994-09-19 |
1996-04-09 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel medicinal use of 5ht3 antagonist
|
|
GB9514464D0
(en)
|
1995-07-14 |
1995-09-13 |
Glaxo Lab Sa |
Medicaments
|
|
GB9524681D0
(en)
|
1995-12-02 |
1996-01-31 |
Knoll Ag |
Chemical process
|
|
DE19632423A1
(de)
|
1996-08-12 |
1998-02-19 |
Merck Patent Gmbh |
Thienopyrimidine
|
|
GB9619757D0
(en)
|
1996-09-21 |
1996-11-06 |
Knoll Ag |
Chemical process
|
|
GB9619962D0
(en)
|
1996-09-25 |
1996-11-13 |
Knoll Ag |
Medical treatment
|
|
GB9619961D0
(en)
|
1996-09-25 |
1996-11-13 |
Knoll Ag |
Medical treatment
|
|
US5795880A
(en)
|
1996-12-30 |
1998-08-18 |
Louisiana State University Medical Center Foundation |
Method and composition for treating obesity and related disorders in animals comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent
|
|
US6127363A
(en)
|
1997-10-28 |
2000-10-03 |
Vivus, Inc. |
Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
GB9727131D0
(en)
|
1997-12-24 |
1998-02-25 |
Knoll Ag |
Therapeutic agents
|
|
US6331571B1
(en)
*
|
1998-08-24 |
2001-12-18 |
Sepracor, Inc. |
Methods of treating and preventing attention deficit disorders
|
|
US6323242B1
(en)
*
|
1998-12-02 |
2001-11-27 |
Peter Sterling Mueller |
Treatment of disorders secondary to organic impairments
|
|
WO2000056309A1
(en)
*
|
1999-03-19 |
2000-09-28 |
Knoll Pharmaceutical Company |
Method of treating sexual dysfunction
|